ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Ivz At1 Cap Gbp

Ivz At1 Cap Gbp (AT1S)

3,410.50
-2.50
(-0.07%)
Cerrado 07 Enero 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
3,410.50
Postura de Compra
3,402.50
Postura de Venta
3,418.50
Volume Operado de la Acción
2,132
3,408.00 Rango del Día 3,415.75
0.00 Rango de 52 semanas 0.00
Precio Anterior
3,413.00
Precio de Apertura
3,408.00
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
7p
Precio Promedio Ponderado
0.3408

AT1S Últimas noticias

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 07 January 2025   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 06 January 2025   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 03 January 2025   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 02 January 2025   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 31 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 30 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 27 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 24 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 23 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

IVZ II AT1 Capital Bond HDG Dist £ Net Asset Value(s)

IVZ II AT1 Capital Bond HDG Dist £ 20 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base Invesco AT1 Capital Bond UCITS ETF GBP Hdg Dist Class...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SANASana Biotechnology Inc
US$ 6.09
(269.09%)
23.01M
INVZWInnoviz Technologies Ltd
US$ 0.2764
(37.79%)
44k
CDTConduit Pharmaceuticals Inc
US$ 0.125
(32.98%)
8.83M
JBDIJBDI Holdings Ltd
US$ 0.8799
(24.28%)
6.44M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.1425
(23.91%)
41.8M
XTIAXTI Aerospace Inc
US$ 0.0619
(-45.75%)
209.48M
DRIODarioHealth Corporation
US$ 1.0999
(-28.11%)
374.02k
ALKTAlkami Technology Inc
US$ 25.50
(-27.91%)
13.87k
SVMHSRIVARU Holding Ltd
US$ 0.0657
(-21.79%)
64.12M
AREBAmerican Rebel Holdings Inc
US$ 2.20
(-21.15%)
639.82k
XTIAXTI Aerospace Inc
US$ 0.0619
(-45.75%)
209.48M
SVMHSRIVARU Holding Ltd
US$ 0.0657
(-21.79%)
64.12M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.1425
(23.91%)
41.8M
SANASana Biotechnology Inc
US$ 6.09
(269.09%)
23.01M
RGTIRigetti Computing Inc
US$ 16.29
(-11.42%)
10.01M
vlispxpert vlispxpert 3 minutos hace
CDT .13 after hours ;)
gfp927z gfp927z 4 minutos hace
>>> Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


PR Newswire

January 6, 2025


https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html
ACXP
DiamondHealer95 DiamondHealer95 4 minutos hace
Apologies
KBLB
Number sleven Number sleven 4 minutos hace
Biotech, Why bother to respond. He is a child looking for attention.
Sleven,
AMRN
gfp927z gfp927z 5 minutos hace
>>> Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


PR Newswire

January 6, 2025


https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html
ACXP
TheDane TheDane 5 minutos hace
These people never learn to keep their yaps shut. Sheesh.
But this seems to a quantum thing. Arequipa, retired, drum, Ionq, all down after the close.
IONQ
stealofadeal stealofadeal 5 minutos hace
$CBDL It's a loss the second you buy. This POS dropped to .0003 before the paint hit it the end of the day on bu!!sh!t WalMart news
CBDL
gfp927z gfp927z 6 minutos hace
>>> Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


PR Newswire

January 6, 2025


https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html
ACXP
DewDiligence DewDiligence 6 minutos hace
Metsera is trying to get some big pharma to buy them by releasing a flashy PR. No other reason for a private firm to do this PR now IMO.The PR could also be intended to facilitate a financing round.
wakeupdummy wakeupdummy 6 minutos hace
could be breaking out of trips tomorrow!
very positive news today
ASII
EnchantedTitan62 EnchantedTitan62 6 minutos hace
Maybe Mr Dell is buying another home, a bigger boat, paying for someones education, ...it's his money just sitting there. If he chooses to spend it that's his decision. May all your trades be profitable.
DELL
Tr8dervic Tr8dervic 6 minutos hace
Thanks Eli.

What say the rest of you?
trunkmonk trunkmonk 6 minutos hace
No why?
XRPUSD
penguin007 penguin007 6 minutos hace
Still not understanding the extremely low volume here day after day? Just seems kind of strange, unless float is already bought up and being held onto by some of us, the stronger hands, the smarter hands! lol
ZHUD
EternalPatience EternalPatience 7 minutos hace
Tim Howard believes that the latest pspa is not pro release but more of a delay tactic to perpetual conservatorship. That's what I had thought as well. Of course, it can superceded with another agreement between new fhfa and new tsy granted but I am surprised why the market thinks this pspa amendmen
FNMA
improving improving 7 minutos hace
I'm losing all respect for your bash pieces.
WRT to your reply post, thanks for slowing it down, I think I've got it:

Xmaster speaks for the company and knows what they knew and when they knew it.
Dr Liau's presentation was really NorthWest's presentation, even though
NWBO
AES3 AES3 7 minutos hace
When they announced the investor call the market close wasn't announced yet
LWLG
europa7 europa7 7 minutos hace
UK Department of Energy & Climate Change ~ Smart Metering Implementation Programme
https://www.parliament.uk/globalassets/documents/commons-committees/public-accounts/SMIP-PAC-2014-Progress-Update-Report-FINAL.pdf

Smart Metering Implementation Programme ~ domestic leaflet
LAES
DewDiligence DewDiligence 8 minutos hace
Re: FDA’s updated (draft) guidance on obesity trials

Apparently the FDA now considers a responder analysis inappropriate for a primary endpoint and perhaps a dubious choice even for a secondary endpoint. From Page 9 of the draft guidance: Responder analyses on continuous variables (i.
BMI
quigley24 quigley24 8 minutos hace
no vol much....our day is coming and VERY SOON
CNRC
Deannie Deannie 8 minutos hace
K snapped his fingers with yet another inconsequential PR, so I’m back until the next one drops.

Where to begin… “By February”. That’s funny. Is February, like the AF? A slam dunk? Is 2022 the year? 2023? 2024? 2025? 2026? Is he greater? No, he isn’t. By the close of February you’ll a
KBLB
dinogreeves dinogreeves 9 minutos hace
Cause I got in at $4.00 yesterday after hours. Placed a stop loss at 3.85 and it got taken out, should have sold with 5 grand profits this morning. Oh well on to the next one.
SMCI
Brooge warrants cancelled Brooge warrants cancelled 9 minutos hace
https://x.com/Snarkytrashpan2/status/1876474428693070180
FNMA
Mountdallas Mountdallas 9 minutos hace
Dude 99% of crypto is a scam and either a rug or slow rug lol. Theres a new coin created every minute. The OTC is a far safer place to do a high risk trade. The "CEO" 🥴 of a crypto coin can just gank the liquidity pool at a moments notice with zero repercussion and take your entire investmen
SNPW
Jahvik Jahvik 9 minutos hace
Dude, I'd buy Trumps place in West Palm at .10
HMBL

Su Consulta Reciente

Delayed Upgrade Clock